Literature DB >> 15999358

Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.

Ketayun Ardeshir Dinshaw1, Jai Prakash Agarwal, Sarbani Ghosh Laskar, Tejpal Gupta, Shyam Kishore Shrivastava, Anil D Cruz.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is one of the leading cancers in India. Since a large majority present in loco-regionally advanced stages, surgery followed by adjuvant post-operative radiotherapy (PORT) has been the mainstay of treatment for resectable HNSCC. AIM: To identify clinico-pathologic factors that could have an impact on outcome in HNSCC in the postoperative setting.
MATERIALS AND METHODS: A retrospective review of 348 previously untreated patients with HNSCC who received PORT following curative surgery. The outcome measures were local control, loco-regional control, and disease free survival (DFS).
RESULTS: With a median follow-up of 36 months (range: 2-127 months) for surviving patients, the 5-year local control, loco-regional control, and DFS was 79%, 63%, and 56%, respectively for all patients. On univariate analysis, site of primary was an independent prognostic factor for all the outcome measures (P = 0.005, 0.02, and 0.04, respectively) with oral cavity lesions faring the worst. Peri-nodal extension (PNE) affected loco-regional control (P = 0.002) and DFS (P = 0.0005), but was not predictive for local control (P = 0.9852). Cut margin positivity predicted for inferior local control alone (P = 0.03), the significance of which was lost on multivariate analysis. Cox regression analysis however confirmed the significance of primary site and PNE as independent prognostic factors.
CONCLUSION: Primary site and PNE are independent factors predicting outcome in the postoperative radiotherapeutic management of HNSCC.

Entities:  

Mesh:

Year:  2005        PMID: 15999358     DOI: 10.1002/jso.20274

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

2.  Current management of advanced resectable oral cavity squamous cell carcinoma.

Authors:  Thomas J Ow; Jeffrey N Myers
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-03-17       Impact factor: 3.372

3.  Ten-Year Outcome of Different Treatment Modalities for Squamous Cell Carcinoma of Oral Cavity

Authors:  Imjai Chitapanarux; Patrinee Traisathit; Nicha Komolmalai; Sompol Chuachamsai; Pichit Sittitrai; Tienchai Pattarasakulchai; Rak Tananuwat; Donyarat Boonlert; Patumrat Sripan; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

4.  Retrospective study on factors affecting the prognosis in oral cancer patients who underwent surgical treatment only.

Authors:  Byeong-Guk Kim; Jun-Hwa Kim; Myung-In Kim; Jeong Joon Han; Seunggon Jung; Min-Suk Kook; Hong-Ju Park; Sun-Youl Ryu; Hee-Kyun Oh
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.